Differences in P-glycoprotein activity in human and rodent blood–brain barrier assessed by mechanistic modelling
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0738
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Differences in P-glycoprotein activity in human and rodent blood–brain barrier assessed by mechanistic modelling ; volume:95 ; number:9 ; day:15 ; month:7 ; year:2021 ; pages:3015-3029 ; date:9.2021
Archives of toxicology ; 95, Heft 9 (15.7.2021), 3015-3029, 9.2021
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00204-021-03115-y
- URN
-
urn:nbn:de:101:1-2021110720221921093245
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Verscheijden, Laurens F. M.
- Koenderink, Jan J.
- Wildt, Saskia N. de
- Russel, Frans G. M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
Decreased blood-brain barrier P-glycoprotein function with aging
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET
P-glycoprotein transporter in drug development
[11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein
Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET
P-glycoprotein Function in the Rodent Brain Displays a Daily Rhythm, a Quantitative In Vivo PET Study
Inhibition of P-glycoprotein by two artemisinin derivatives
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Protecting P-glycoprotein at the blood–brain barrier from degradation in an Alzheimer’s disease mouse model
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
Decreased blood-brain barrier P-glycoprotein function with aging
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET
P-glycoprotein transporter in drug development
[11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein
Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET
P-glycoprotein Function in the Rodent Brain Displays a Daily Rhythm, a Quantitative In Vivo PET Study
Inhibition of P-glycoprotein by two artemisinin derivatives
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Protecting P-glycoprotein at the blood–brain barrier from degradation in an Alzheimer’s disease mouse model
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
Decreased blood-brain barrier P-glycoprotein function with aging
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET
P-glycoprotein transporter in drug development
[11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein
Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET
P-glycoprotein Function in the Rodent Brain Displays a Daily Rhythm, a Quantitative In Vivo PET Study
Inhibition of P-glycoprotein by two artemisinin derivatives
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids